|
Computational modeling for circulating cell-free DNA in clinical oncology
Linh Nguyen Phuong
,
Sébastien Salas
,
Sébastien Benzekry
Journal articles
hal-04481689
v3
|
|
Predicting Survival in Patients with Advanced NSCLC Treated with Atezolizumab Using Pre‐ and on‐Treatment Prognostic Biomarkers
Sébastien Benzekry
,
Mélanie Karlsen
,
Célestin Bigarré
,
Abdessamad El Kaoutari
,
Bruno Gomes
et al.
Journal articles
hal-04647230
v1
|
|
A senescence-mimicking (senomimetic) VEGFR TKI side-effect primes tumor immune responses via IFN/STING signaling
Melissa Dolan
,
Yuhao Shi
,
Michalis Mastri
,
Mark Long
,
Amber Mckenery
et al.
Journal articles
hal-04571490
v1
|
|
Mechanistic Learning for Predicting Survival Outcomes in Head and Neck Squamous Cell Carcinoma
Kevin Atsou
,
Anne Auperin
,
Jôel Guigay
,
Sébastien Salas
,
Sébastien Benzekry
Journal articles
hal-04558029
v2
|
|
Lack of Prophylactic Cranial Irradiation for Extensive Small-Cell Lung Cancer in Real Life, with the Emergence of Immunotherapy
Alice Daumas
,
Celestin Bigarre
,
Mohamed Boucekine
,
Audrey Zaccariotto
,
Bertrand Kaeppelin
et al.
Journal articles
hal-04863847
v1
|
|
Acquired resistance to PD-L1 inhibition enhances a type I IFN-regulated secretory program in tumors
Yuhao Shi
,
Amber Mckenery
,
Melissa Dolan
,
Michalis Mastri
,
James W Hill
et al.
Journal articles
hal-04387866
v2
|
|
Machine-learning and mechanistic modeling of primary and metastatic breast cancer growth after neoadjuvant targeted therapy
Sébastien Benzekry
,
Michalis Mastri
,
Chiara Nicolò
,
John Ebos
Journal articles
hal-04384182
v2
|
|
Mechanistic modeling of metastatic relapse in early breast cancer to investigate the biological impact of prognostic biomarkers
Célestin Bigarré
,
François Bertucci
,
Pascal Finetti
,
Gaëtan Macgrogan
,
Xavier Muracciole
et al.
Journal articles
hal-04008520
v1
|
|
Reuniting philosophy and science to advance cancer research.
Thomas Pradeu
,
Bertrand Daignan-Fornier
,
Andrew Ewald
,
Pierre-Luc Germain
,
Samir Okasha
et al.
Journal articles
hal-04190936
v1
|
|
Computational markers for personalized prediction of outcomes in non-small cell lung cancer patients with brain metastases
Sébastien Benzekry
,
Pirmin Schlicke
,
Alice Mogenet
,
Laurent Greillier
,
Pascale Tomasini
et al.
Journal articles
hal-04360487
v1
|
|
Des modèles mathématiques pour la recherche clinique en cancérologie
Sébastien Benzekry
Journal articles
hal-03746564
v1
|
|
Macro-scale models for fluid flow in tumour tissues: impact of microstructure properties
Cristina Vaghi
,
Raphaëlle Fanciullino
,
Sébastien Benzekry
,
Clair Poignard
Journal articles
hal-02891573
v1
|
|
Practical identifiability analysis of a mechanistic model for the time to distant metastatic relapse and its application to renal cell carcinoma
Arturo Álvarez-Arenas
,
Wilfried Souleyreau
,
Andrea Emanuelli
,
Lindsay S Cooley
,
Jean-Christophe Bernhard
et al.
Journal articles
hal-03921339
v1
|
|
Asymptotic analysis of a biphase tumor fluid flow: the weak coupling case.
Cristina Vaghi
,
Sébastien Benzekry
,
Clair Poignard
Journal articles
hal-03354766
v2
|
|
Tumor growth monitoring in breast cancer xenografts: A good technique for a strong ethic
Anne Rodallec
,
Cristina Vaghi
,
Joseph Ciccolini
,
Raphaëlle Fanciullino
,
Sebastien Benzekry
Journal articles
hal-03924541
v1
|
|
Machine Learning for Prediction of Immunotherapy Efficacy in Non-Small Cell Lung Cancer from Simple Clinical and Biological Data
Sébastien Benzekry
,
Mathieu Grangeon
,
Mélanie Karlsen
,
Maria Alexa
,
Isabella Bicalho-Frazeto
et al.
Journal articles
hal-03478003
v2
|
|
Experimental and computational modeling for signature and biomarker discovery of renal cell carcinoma progression
Lindsay Cooley
,
Justine Rudewicz
,
Wilfried Souleyreau
,
Andrea Emanuelli
,
Arturo Alvarez-Arenas
et al.
Journal articles
hal-03390517
v1
|
|
Development and Validation of a Prediction Model of Overall Survival in High-Risk Neuroblastoma Using Mechanistic Modeling of Metastasis
Sébastien Benzekry
,
Coline Sentis
,
Carole Coze
,
Laëtitia Tessonnier
,
Nicolas André
Journal articles
hal-03147049
v1
|
|
Artificial Intelligence and Mechanistic Modeling for Clinical Decision Making in Oncology
Sébastien Benzekry
Journal articles
hal-02916941
v1
|
|
Population modeling of tumor growth curves and the reduced Gompertz model improve prediction of the age of experimental tumors
Cristina Vaghi
,
Anne Rodallec
,
Raphaëlle Fanciullino
,
Joseph Ciccolini
,
Jonathan P Mochel
et al.
Journal articles
inserm-02515955
v1
|
|
Deciphering the response and resistance to immunecheckpoint inhibitors in lung cancer with artificial intelligence-based analysis: the pioneer and quantic joint-projects
Joseph Ciccolini
,
Sébastien Benzekry
,
Fabrice Barlesi
Journal articles
hal-03147110
v1
|
|
Machine Learning and Mechanistic Modeling for Prediction of Metastatic Relapse in Early-Stage Breast Cancer
Chiara Nicolò
,
Cynthia Périer
,
Mélanie Prague
,
Carine Bellera
,
Gaëtan Macgrogan
et al.
Journal articles
hal-02942177
v1
|
|
Prédiction de l'efficacité de l'immunothérapie dans le cancer bronchique à partir de données cliniques et biologiques simples : apport de l'intelligence artificielle
Mathieu Grangeon
,
Sebastien Benzekry
,
Solène Chaleat
,
Pascale Tomasini
,
Dominique Barbolosi
et al.
Journal articles
hal-03147118
v1
|
|
Mechanistic Learning for Combinatorial Strategies With Immuno-oncology Drugs: Can Model-Informed Designs Help Investigators?
Joseph Ciccolini
,
Dominique Barbolosi
,
Nicolas André
,
Fabrice Barlesi
,
Sébastien Benzekry
Journal articles
hal-03147084
v1
|
|
Combinatorial immunotherapy strategies : most gods throw dice, but fate plays chess
Joseph Ciccolini
,
Dominique Barbolosi
,
Nicolas Andre
,
Sébastien Benzekry
,
Fabrice Barlesi
Journal articles
hal-02383826
v1
|
|
Optimal Scheduling of Bevacizumab and Pemetrexed/cisplatin Dosing in Non‐Small Cell Lung Cancer
Benjamin K Schneider
,
Arnaud Boyer
,
Joseph Ciccolini
,
Fabrice Barlesi
,
Kenneth Wang
et al.
Journal articles
hal-02109335
v1
|
|
Quantitative mathematical modeling of clinical brain metastasis dynamics in non-small cell lung cancer
Maria Bilous
,
Cindy Serdjebi
,
Arnaud Boyer
,
Claudia Pouypoudat
,
Pascale Tomasini
et al.
Journal articles
hal-01928442
v2
|
|
Is There Any Room for Pharmacometrics With Immuno-Oncology Drugs? Input from the EORTC-PAMM Course on Preclinical and Early-phase Clinical Pharmacology
Anne Rodallec
,
Raphaelle Fanciullino
,
Sébastien Benzekry
,
Joseph Ciccolini
Journal articles
hal-02383831
v1
|
|
CAR T-Cell Immunotherapy in Human and Veterinary Oncology: Changing the Odds Against Hematological Malignancies
Jonathan Paul M. Mochel
,
Stephen C Ekker
,
Chad Johannes
,
Albert E Jergens
,
Karin Allenspach
et al.
Journal articles
hal-02099159
v1
|
|
Combinatorial immunotherapy strategies: most gods throw dice, but fate
Joseph Ciccolini
,
Dominique Barbolosi
,
Nicolas André
,
Sebastien Benzekry
,
Fabrice Barlesi
Journal articles
hal-03147132
v1
|
|
Turning cold tumors into hot tumors: harnessing the potential of tumor immunity using nanoparticles
Anne Rodallec
,
Guillaume Sicard
,
Raphaelle Fanciullino
,
Sébastien Benzekry
,
Bruno Lacarelle
et al.
Journal articles
hal-01958583
v1
|
|
Revisiting bevacizumab + cytotoxics scheduling using mathematical modeling: proof of concept study in experimental non-small cell lung carcinoma
Diane-Charlotte Imbs
,
Raouf El Cheikh
,
Arnaud Boyer
,
Joseph Ciccolini
,
Celine Mascaux
et al.
Journal articles
hal-01624423
v2
|
|
Pharmacokinetics variability: why nanoparticles are not magic bullets in oncology
Anne Rodallec
,
Sébastien Benzekry
,
Bruno Lacarelle
,
Joseph Ciccolini
,
Raphaelle Fanciullino
Journal articles
hal-01821678
v1
|
|
Mathematical modeling of tumor-tumor distant interactions supports a systemic control of tumor growth
Sébastien Benzekry
,
Clare Lamont
,
Dominique Barbolosi
,
Lynn Hlatky
,
Philip Hahnfeldt
Journal articles
hal-01566947
v1
|
|
Model-driven optimization of antiangiogenics + cytotoxics combination: application to breast cancer mice treated with bevacizumab + paclitaxel doublet leads to reduced tumor growth and fewer metastasis
Severine Mollard
,
Joseph Ciccolini
,
Diane-Charlotte Imbs
,
Raouf El Cheikh
,
Dominique Barbolosi
et al.
Journal articles
hal-01474679
v1
|
|
Non-standard radiotherapy fractionations delay the time to malignant transformation of low-grade gliomas
Araceli M Henares-Molina
,
Sébastien Benzekry
,
Pedro C Lara
,
Marcial M García-Rojo
,
Víctor M Pérez-García
et al.
Journal articles
hal-01532505
v1
|
|
Etude de l'effet séquence bevacizumab/pemetrexed/cisplatine chez la souris porteuse de cancer du poumon non à petites cellules
Arnaud Boyer
,
Joseph Ciccolini
,
Céline Mascaux
,
Diane-Charlotte Imbs
,
Raouf El Cheikh
et al.
Journal articles
hal-01540322
v1
|
|
Dose- and time-dependence of the host-mediated response to paclitaxel therapy: a mathematical modeling approach
Madeleine Benguigui
,
Dror Alishekevitz
,
Michael Timaner
,
Dvir Shechter
,
Ziv Raviv
et al.
Journal articles
hal-01672568
v1
|
|
In Vivo Bioluminescence Tomography for Monitoring Breast Tumor Growth and Metastatic Spreading: Comparative Study and Mathematical Modeling
Séverine Mollard
,
Raphaelle Fanciullino
,
Sarah Giacometti
,
Cindy Serdjebi
,
Sebastien Benzekry
et al.
Journal articles
hal-01392861
v1
|
|
Modeling Spontaneous Metastasis following Surgery: An In Vivo-In Silico Approach
Sébastien Benzekry
,
Amanda Tracz
,
Michalis Mastri
,
R. Corbelli
,
Dominique Barbolosi
et al.
Journal articles
hal-01222046
v2
|
|
Next generation metronomic chemotherapy - report from the Fifth Biennial International Metronomic and Anti-angiogenic Therapy Meeting, 6 - 8 May 2016, Mumbai
Pan G Pantziarka
,
Lisa Hutchinson
,
Nicolas G André
,
Sébastien Benzekry
,
Francesco Bertolini
et al.
Journal articles
hal-01392473
v1
|
|
Les lois de la croissance tumorale
Sébastien Benzekry
Bibliothèque Tangente, 2016
Journal articles
hal-01418295
v1
|
|
Mathematical modeling of cancer immunotherapy and its synergy with radiotherapy
R. Serre
,
Sébastien Benzekry
,
Laetitia Padovani
,
C. Meille
,
N. Andre
et al.
Journal articles
hal-01336779
v1
|
|
Metronomic Reloaded: Theoretical Models Bringing Chemotherapy into the Era of Precision Medicine
Sébastien Benzekry
,
Eddy Pasquier
,
Dominique Barbolosi
,
Bruno Lacarelle
,
Fabrice Barlési
et al.
Journal articles
hal-01195547
v1
|
|
Computational Modelling of Metastasis Development in Renal Cell Carcinoma
Etienne Baratchart
,
Sébastien Benzekry
,
Andreas Bikfalvi
,
Thierry Colin
,
Lindsay S. Cooley
et al.
Journal articles
hal-01164834
v2
|
|
Improving efficacy of the combination between antiangiogenic and chemotherapy: Time for mathematical modeling support
Joseph Ciccolini
,
Sébastien Benzekry
,
Bruno Lacarelle
,
Dominique Barbolosi
,
Fabrice Barlesi
Journal articles
hal-01168635
v1
|
|
Design principles for cancer therapy guided by changes in complexity of protein-protein interaction networks
Sebastien Benzekry
,
Jack A Tuszynski
,
Edward A Rietman
,
Giannoula Lakka Klement
Journal articles
hal-01158313
v1
|
|
Host Age Is a Systemic Regulator of Gene Expression Impacting Cancer Progression
Afshin Beheshti
,
Sebastien Benzekry
,
J. Tyson Mcdonald
,
Lili Ma
,
Michael Peluso
et al.
Journal articles
hal-01132048
v1
|
|
Capturing the Driving Role of Tumor-Host Crosstalk in a Dynamical Model of Tumor Growth
Sebastien Benzekry
,
Afshin Beheshti
,
Philip Hahnfeldt
,
Lynn Hlatky
Bio-protocol , 2015, 5 (21)
Journal articles
hal-01222068
v1
|
|
Classical Mathematical Models for Description and Forecast of Experimental Tumor Growth
Sébastien Benzekry
,
Clare Lamont
,
Afshin Beheshti
,
Amanda Tracz
,
John M.L. Ebos
et al.
Journal articles
hal-00922553
v6
|
|
Global Dormancy of Metastases due to Systemic Inhibition of Angiogenesis
Sébastien Benzekry
,
Alberto Gandolfi
,
Philip Hahnfeldt
Journal articles
hal-00868592
v3
|
|
Theoretical investigation of the efficacy of antiangiogenic drugs combined to chemotherapy in xenografted mice.
Floriane Lignet
,
Sébastien Benzekry
,
Shelby Wilson
,
Frédérique Billy
,
Olivier Saut
et al.
Journal articles
istex
hal-00785876
v1
|
|
Maximum tolerated dose versus metronomic scheduling in the treatment of metastatic cancers.
Sebastien Benzekry
,
Philip Hahnfeldt
Journal articles
hal-00836032
v1
|
|
A new mathematical model for optimizing the combination between antiangiogenic and cytotoxic drugs in oncology
Sébastien Benzekry
,
Guillemette Chapuisat
,
Joseph Ciccolini
,
Alice Erlinger
,
Florence Hubert
Journal articles
hal-00641476
v2
|
|
Mathematical and numerical analysis of a model for anti-angiogenic therapy in metastatic cancers
Sebastien Benzekry
ESAIM: Mathematical Modelling and Numerical Analysis, 2012, 46 (2), pp.207-237
Journal articles
hal-00518110
v1
|
|
Modeling the impact of anticancer agents on metastatic spreading
Sébastien Benzekry
,
Nicolas André
,
Assia Benabdallah
,
Joseph Ciccolini
,
Christian Faivre
et al.
Journal articles
hal-00657724
v1
|
|
Passing to the limit 2D-1D in a model for metastatic growth
Sebastien Benzekry
Journal articles
hal-00521968
v1
|
|
Mathematical analysis of a two-dimensional population model of metastatic growth including angiogenesis
Sebastien Benzekry
Journal of Evolution Equations, 2011, 11 (1), pp.187-213
Journal articles
hal-00516693
v1
|